Lung Cancer

Latest News

Crystal light-stock.adobe.com
Trial Supports Bizengri as a Promising Treatment for NRG1 Fusion-Positive Cancers, Including Advanced Lung Cancer

April 3rd 2025

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for Bizengri (zenocutuzumab) as a promising treatment option.

technician looking at patient getting CT scan of lungs | image credit: ©peakstock stock.adobe.com
Study Finds Adherence to Annual Lung Cancer Screening Linked to Higher Detection Rates

March 18th 2025

Regeneron Canada Reaches New Agreement Deal for Cancer Drug Libtayo
Regeneron Canada Reaches New Agreement Deal for Cancer Drug Libtayo

March 7th 2025

conceptual image of lung with nodule | image credit: ©TensorSpark
Incidental Lung Nodule Detection May Help Save Lives, Study Finds

March 7th 2025

cancer immunotherapy imagery,  a spikey cell | image credit: @TensorSpark stock.adobe.com
Study Explores Immunotherapy vs. Chemoimmunotherapy Decisions For Advanced Non-Small Lung Cancer

March 5th 2025

Video Interviews
Latest CME Events & Activities

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

April 4, 2025 | New York, NY & Virtual

Register Now!

Community Practice Connection™: 21st Annual Winter Lung Cancer Conference®

View More

Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights Into Predicting Pathologic Responses to Immunotherapies

View More

BURST CME™: How Are Emerging Biomarkers and Testing Methodologies Shaping Personalized Medicine in NSCLC?

View More

Navigating Current State-of-the Art NSCLC Patient Care From the Front Lines: Essentials for Oncology Nurses Today and Tomorrow

View More

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

View More

Top 10 Oncogenic Drivers in NSCLC for 2024: Where Are We and Where Are We Going?

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

DLL3 as a Therapeutic Target in SCLC and Beyond: Rationale, Recent Data and Potential for Transformations in Care with T-Cell Engagers

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

Advances In™: Moving Care Forward in SCLC with DLL3 Targeting Bispecific T-Cell Engagers

View More

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

What’s Next for HER2- and TROP2-Directed ADCs in Lung Cancer: How Emerging Trial Data will Impact our Clinics Today, and Tomorrow….

View More

Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real-World Settings, What’s Next for Emerging Novel Strategies

View More

Community Practice Connections™: 25th Annual International Lung Cancer Congress

View More

Community Practice Connections™: 8th Annual School of Nursing Oncology™

View More

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Virtual Tumor Board for the Onco-Nurse: Improving Outcomes in SCLC Treatment and AE Management

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies

View More

Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L

View More

Burst CME™: Exploring Diagnosis and Testing Innovations for Targetable Mutations in SCLC

View More

Burst CME™: Advanced Diagnostic and Testing Approaches for Mutation-Targetable Management of NSCLC

View More

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

More News

© 2025 MJH Life Sciences

All rights reserved.